Description
Tirzepatide
A synthetic derivative of gastric inhibitory polypeptide (GIP) that has simultaneous glucagon-like peptide-1 (GLP-1) functionality as well. This combination allows Tirzepatide to lower blood glucose levels, increase insulin sensitivity, boost feelings of satiety, and accelerate weight loss. Tirzepatide was developed to fight type 2 diabetes, but has additionally been shown to protect the cardiovascular system and act as a potent weight loss agent.
Clinically shown to support significant weight loss, Tirzepatide is administered via a once-weekly injection and is marketed under the brand name Mounjaro. It is quickly becoming a popular option for those struggling with obesity or metabolic issues when combined with proper diet and exercise
Reviews
There are no reviews yet.